Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06373575

IVC and Lung Ultrasound B-lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure

Inferior Vena Cava and Lung Ultrasound B-lines Guided Decongestion in Critically Ill Kidney Failure Patients With Heart Failure: a Single-center, Prospective, Randomized Controlled Intervention Study

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objectives of this trial are to determine whether, in critically ill ESKD patients randomization to fluid removal guided by lung and inferior vena cava ultrasound, compared to standard care, leads to Improved pulmonary congestion (primary outcome); and safety (secondary outcome) in the short-term.

Detailed description

The point-of-care ultrasound was thought useful in the management of fluid in critically ill patients. At present, the role of the lung and inferior vena cava ultrasound is unclear in the management of decongestion of heart failure in kidney failure (KF) patients using prolonged hemodialysis. The investigators aim to explore the effect of pre-dialysis probing with the lung and inferior vena cava to guide fluid removal as compared with conventional protocols on the improvement of heart failure symptoms in patients with KF with heart failure under prolonged hemodialysis in the short-term.

Conditions

Interventions

TypeNameDescription
PROCEDURELung and inferior vena cava ultrasound guidanceThe lung and inferior vena cava ultrasound will be utilized as guidance for the development of a dialysis prescription for prolonged hemodialysis.
PROCEDUREConventional protocol guidanceFluid removal using conventional protocol including blood pressure and physical examination

Timeline

Start date
2024-05-01
Primary completion
2025-04-30
Completion
2025-06-30
First posted
2024-04-18
Last updated
2024-04-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06373575. Inclusion in this directory is not an endorsement.